Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

nursing 141 > neuro (class 9) degenerative diseases > Flashcards

neuro (class 9) degenerative diseases Flashcards

1
Q

dementia

A

cognitive decline caused by any disorder that permanently damages areas of the brain necessary for memory & learning.

progressive impairment of cognitive function, personality & behavior.

um brella term for disorders that result in neuron death or loss of communication between cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dementia risk factors

A

age, family history, smoking/ETOH use, ethnicity, diseases: high cholesterol, atherosclerosis, DM, down’s syndrome, TBI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

various types of dementia

A 
Alzheimer's disease
vascular dementia
lewy body dementia
fronto-temporal dementia
mixed dementia
reversible causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alzeimer’s disease

pathophysiology

A

cause unknown-interaction of multiple factors.

brain changes: loss of nerve cells & vascular supply causing brain atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

neurotic plaques

A

group of degenerated cells that clump around amyloid core begin in areas for cognition & memory, disrupt transmission of nerve impulses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tangles

A

twisted fibers of tau protein that build up cytoplasm of affected neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

progressive alzheimers

A

more areas of the brain over time- loss of neurons/neurotransmitters with enlargement of ventricles & structural changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

alzheimer’s manifestations

A

dementia often categorized as mild-moderate-severe.

7 stage classification systme.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

stages 1-2 mild

A

trouble finding words, decrease memory & planning, lose objects, social & work problems, stage 3 may become noticable to others & measurable in exams.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

stages 4&5 moderate

A

ST memory loss, loss of mental functions, can’t perform complex tasks, become withdrawn, may need ADL assist, poor recall, disorientation to place, time, context

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stages 6&7 severe

A

worsening memory, personality changes, lose context, need supervision, sleep-wake cycle disruptions, wandering, personality changes, suspicious, in final stage lose ability to respond to environment, speech, & purposeful movement, decrease reflexes, muscle rigidity, swallowing impairments, vision loss, malnutrition & aspiration are frequent complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

alzheimers diagnosis

A

no single specific test to R/O things that mimic.

medical & medication hx. unintentional wt loss. hx of behavior patterns over time, lab work. physical exam. neuro exams, mood evaluation, cognitive testing. brain scans: CT, MRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment meds

A

meds for memory- slow progression.
acetylcholinesterase inhibitors-donepezil.

prevents breakdown of ACH=enhanced neuron activity
NMDA receptor antagonist-memantine.
reduces glutamate & blocks excessive Ca entry into cells =prevent cell death

meds for behaviors-antidepressants, anxiolytics, antipsychotics.

meds for sleep changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatment: non-med strategies

A

reminiscence, validation therapy, cueing, reality orientation, manage aggression: space, low stimuli environment, distraction, alternative activities, touch-caution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dementia

A 
group of cognitive disorders
could have problems with memory, judgement, using and understanding language and motor function.
result in death of neurons.
gradual onset, slow decline,
no cure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

delirium

A

caused by underlying medical problem.
occurs abruptly
symptoms fluctuate throughout day.
more profound state of confusion, delusions, and agitation.
other medical problem is identified and treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

confusion

A

mild form of delirium
acute change in mental status
abnormal & fluctuation change in attention.
may give warning of development of more severe disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

creutzfeldt-jakob disease

cause

A

prion disorder(protein) cns disease, effects dependent on where proteins are active. familial, sporadic, or infections causes buildup of abnormal prion proteins. 4+ yr incubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

creutzfeldt-jakob disease symptoms

A

rapid progression (wks to months). behavior & personality changes. CNS: memory, vision loss, dysphagia, abnormal movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

creutzfeldt-jakob disease diagnosis

A

can only by confirmed by autopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

creutzfeldt-jakob disease treatment

A

supportive only

22
Q

parkinsons disease pathophysiology

A

chronic & gradually progressive, classes as movement disorder but sensory s/s.

risk factors: age, exposure to toxins, head injury, sex.

neurotransmitter problem: death of dopaminergic neurons in substantia nigra.

23
Q

parkinsons disease manifestations- movement

A 
bradykinesia-slow movement.
rigidity-stiffness cogwheel rigidity.
tremors- resting.
postural instability
additional motor manifestations: stooped posture & gait disturbances-no arm swing, shuffling, festinating, dyskinesia, dystonia, freezing, facial masking, swallowing problems, drooling, micrographia, dysphonia.
24
Q

parkinsons disease manifestations- nonmovement

A

cognitive changes: attention, planning, language, memory, dementia, constipation, fatigue, loss of taste or smell, urinary urgency, frequency, sleep problems, mood disorders: depression, anxiety, paathy, irritability. early satiety, wt loss, orthostatic hypotension, dizziness.

25
parkinsons disease diagnosis
no specific test- must have 2 of the 4 symptoms. neurologist movement disorders specialist- challenging dx, pts have variable symptoms. R/O other conditions that mimic. tests: ct scan mri, datscan SPECT: shows density of dopamine transporter, qualatative. PET SCAN
26
parkinsons disease treatment
no cure, meds & treatments control symptoms, eventually not effective. medications: dopamine replacement: levodopa/carbidopa dopamine agonists= stimulate areas of brain where dopamine works. Anticholinergics- treat tremor by blocking acetycholine. MAO inhibitors- prevent breakdown of dopamine medical marijuanna. surgery-deep brain stimulator. therapy.
27
multiple sclerosis
autoimmune= B cells invade/stimulate inflammation & scarring. central nervous system. destruction of myelin sheath. motor & sensory nerves are impacted. lesions happen in different areas so clinical s/s individualized.
28
MS manifestations
fatigue is very common. visual impairments, nystagmus. sensory: pain, paresthesia, numbness, balance impairments (+rombergs) cognitive: memory loss, judgement/planning, concentration impaired. mood: unstable emotions, depression, anxiety. motor: stiff, slow, weakness, spastic paresis, impaired gait. bladder: urgency, retention, incontinence. bowel: constipation, incontinence sexual dysfunction.
29
MS diagnosis
process- no specific test. medical history- exacerbations of symptoms followed by remission neuro exam: cranial nerves, coordination, strength, reflexes, sensation MRI: lesions, atrophy. lumbar puncture: looking for elevate immune proteins/ evoked potential studies: apply stimuli & measure how long it takes to reach the brain.
30
MS treatment
goal to arrest progress early- remyelination can occur if damage isn't too deep.
31
MS medications
disease-modifying therapies: decrease lesions, decrease frequency & severity of relapse, slow progression. corticosteroids decrease inflammation, immunsuppressants decrease immune response, interferon decreases immune response, glatiramer acetate stimulates myelin proteins. fingolimod traps immune cells in the lymph nodes.
32
MS symptom management
fatigue-amanatadine, modafinial. bladder-anticholinergics for OAB, cholinergic for retention, spasticity-muscle relaxants, benzodiaepine. bowel-stool softeners, laxatives. tremors-beta blockers.
33
MS treatment
surgery- tendon release, placement of intrathercal infusion pump for baclofen. lifestyle: diet nutrition various diets in the research, supplements: vitamin D, probitoics, safety concerns- problems with chewing and swalling. sleep activity identify triggers: stress fatigue infection smoking med changes heat
34
amyotrophic lateral sclerosis
progressive neurodegeneration, degeneration/death of upper and lower motor neurons in brain & spinal cord. begins as a focal process then spreads to impact all levels of the motor system. weakness, wasting, and paralysis of the muscles of the limbs and trunk controlling voluntary movement. most sporadic but 5-10% familiail. risk factors age 40-70 men more likely. smoking. veterans twice as likely.
35
amyotrophic lateral sclerosis manifestations
gradual onset- initial symptoms vary and can be subtle progression of painless muscle weakness. s/s: tripping, dropping things, fatigue of extremities, slurred speech, muscle cramps, fasciculations(twitching), uncontrollable periods of laughing/crying.
36
amyotrophic lateral sclerosis diagnosis
difficult to diagnos- no specific test & involves ruling out other neuro disease. diagnostic procedures to r/o other causes: electromyography & nerve conduction tests, blood & urine tests, thyroid/parathyroid hormone levels, heavy metals, lumbar puncture, MRI, muscle nerve biopsy
37
amyotrophic lateral sclerosis treatment
supporitve care. medication: riluzole: reduce damage to motor neurons by decreasing levels of neurotransmitter messages between nerve cells & motor neuron. edaravone: decrease oxidative stress & slows progression of disease. symptom management. therapy: PT OT ST nutrition support respiratory support end of life care planning.
38
Huntington's disease
genetic disorder- autosomal dominant. onset: @ 30-50 yrs old. degenerative and fatal- long duration of illness 15-20 yrs abnormal folded proteins. damage to basal ganglia which regulates voluntary movement, learning, decision making, cognition, & emotion
39
huntingtons disease manifestations
abnormal muscle movement- progressive loss of control of movement chorea. intellectual decline- impaired interaction & communication memory & attention defecits emotional disturbances- depression, personality change- can be aggressive, paranoid, unstable mood. progressive-late stage can't walk, talk, or eat
40
huntingtons deases diagnosis & treatment
diagnosis: dna testing, number of abnormal copies varies & predicts severity of disease, genetic counseling. treatment- symptomatic only- no way to delay onset or slow progression.
41
Myasthenia gravis
chronic autoimmune neuromuscular disorder of PNS. destroys acetylcholine receptors-> muscle contraction impaired, especially with repetition. causes: thymus gland hyperplasia or tumors produce antibodies- most. other causes- hyperthyroid, RA, lupus.
42
myasthenic crisis
sudden exacerbation, motor weakness, risk of respiratory failure. S/S: tachycardia, tachypnea, respiratory distress, dysphagia, restlessness, speech impairments, anxiety. causes: undermedication, missed med doses, infection/stress
43
cholinergic crisis
life-threatening, motor weakness, risk of respiratory failure. S/S: GI, muscle weakness, vertigo, respiratory distress. cause: overdose of anticholinesterase meds.
44
manifestations of myasthenia gravis
``` dependent on muscles involved. initially eye muscles. facial muscles. fatigue & weakness dysphagia & PNA-respiratory muscles often involved. ``` exac: stress, fever, infection overexertion, heat. relief: rest, better in the AMs.
45
diagnosis of myasthenia gravis
careful hx & phsyical s/s (occular, respiratory, facial,) testing: nerve stimulation tests antiacetylcholine receptro antibodies in seru, anticholinesterase testing complications aspiration pneumonia.
46
myasthenia gravis treatment
medications: anticholinesterases , immunosuppressants surgery: thymectomy. plasma exchange (plasmapheresis)- temporary.
47
Guillain-Barre
segmental demyelination with edema & inflammation of affected nerves. acute & rapidly progressing motor paralysis. impacts muscles, nerves, cranial nerves, LOC not affected. autoimmune, affects all ages, ethnicites & genders. triggers: infections, immunizations, surgery.
48
Guillain barre manifestations
acute onset- progresses over days to 4 weeks. most report precipitating event within 28 days before onset. s/s: bilateral & symmetrical loss of sensation & weakness. begins in feet & spreas upward pain reflexes lost autonomic features at times: up/down BP, arrhythmia, paralytic ileus. may lead to difficulty in breathing
49
guillain barre diagnosis
no specific test. by presettion & correlating hx and tests. lumbar puncture: often proteins in the csf nerve conduction studies show a neuropathy.
50
guillain barre treatment
``` plasma exchange (plasmapheresis) IVGg infusions to suppress antibodies. supportive care-multisystem impacts. rehabilitation: recovery weeks to years. ``` approximately 5% of CBS pts die & up to 20% have persistent disability immunotherapy

nursing 141 (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions